Revance Therapeutics Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
3,989.00
171,107.00
252,338.00
185,528.00
282,896.00
175,812
Total Accounts Receivable
225.00
300.00
158.00
6,026.00
48.00
27,000
Other Current Assets
600.00
1,324.00
1,467.00
1,141.00
2,267.00
5,110
Total Current Assets
4,814.00
172,731.00
253,963.00
192,695.00
285,211.00
207,922
Net Property, Plant & Equipment
14,315.00
19,274.00
19,708.00
10,585.00
9,250.00
14,449
Total Investments and Advances
510.00
435.00
2,151.00
580.00
580.00
730
Other Assets
3,006.00
29.00
-
500.00
658.00
3,247
Total Assets
22,645.00
192,469.00
275,822.00
204,360.00
295,699.00
226,348
ST Debt & Current Portion LT Debt
27,754.00
2,942.00
3,135.00
3,475.00
1,872.00
Accounts Payable
5,526.00
3,149.00
2,657.00
3,754.00
6,805.00
Other Current Liabilities
14,281.00
4,145.00
6,245.00
12,418.00
12,225.00
Total Current Liabilities
47,561.00
10,236.00
12,037.00
19,647.00
20,902.00
Long-Term Debt
3,865.00
598.00
5,346.00
1,872.00
-
Other Liabilities
4,786.00
5,266.00
5,187.00
5,770.00
5,952.00
Total Liabilities
56,212.00
16,100.00
22,570.00
27,289.00
26,854.00
Common Equity (Total)
157,549.00
176,369.00
253,252.00
177,071.00
268,845.00
Total Shareholders' Equity
33,567.00
176,369.00
253,252.00
177,071.00
268,845.00
Total Equity
33,567.00
176,369.00
253,252.00
177,071.00
268,845.00
Liabilities & Shareholders' Equity
22,645.00
192,469.00
275,822.00
204,360.00
295,699.00
Preferred Stock (Carrying Value)
123,982.00
-
-
-
-
About Revance Therapeutics
View Profile
